Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis
- 1 September 2004
- journal article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 106 (4) , 289-293
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volumeActa Neurochirurgica, 2003
- Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implicationsSeminars in Oncology, 2002
- Role of VEGF in an experimental model of cortical micronecrosisAmino Acids, 2002
- Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosisMuscle & Nerve, 2002
- Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disordersSeminars in Cell & Developmental Biology, 2002
- Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factorNeuroscience, 2001
- FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibitionTrends in Pharmacological Sciences, 2001
- Oxidative damage to mitochondrial DNA in spinal motoneurons of transgenic ALS miceMolecular Brain Research, 2001
- Vascular Permeability Factor/Vascular Endothelial Growth Factor: An Important Mediator of Angiogenesis in Malignancy and InflammationInternational Archives of Allergy and Immunology, 1995
- Amyotrophic leteral sclerosis: Part 2. EtiopathogenesisAnnals of Neurology, 1985